EUVIMEDEUVIMED entdecken
Crossref

Bridging the Gap: From Molecular Residual Disease to Curative Opportunity: Circulating Tumor DNA–Guided Surveillance After Curative Resection for Stage I to III Colorectal Cancer

Amandeep Aujla iD, Jibran Ahmed iD

Journal of Clinical Oncology · 10.11.2026 · 44 (32) · 3083-3087

DOI: 10.1200/jco-26-01914 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Oncology, erschienen am 10.11.2026. Verfasst von Amandeep Aujla und 1 weiteren Autor:innen. Beteiligte Einrichtung: Hartford Healthcare Cancer Institute, Backus Hospital, Norwich, CT. Die Arbeit nennt 23 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Hartford Healthcare Cancer Institute, Backus Hospital, Norwich, CT.
  • Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD.

ORCID-Profile: Amandeep Aujla, Jibran Ahmed

Zitieren

APA

Aujla, A., & Ahmed, J. (2026). Bridging the Gap: From Molecular Residual Disease to Curative Opportunity: Circulating Tumor DNA–Guided Surveillance After Curative Resection for Stage I to III Colorectal Cancer. Journal of Clinical Oncology, 44(32), 3083-3087. https://doi.org/10.1200/jco-26-01914

Vancouver

Aujla A, Ahmed J. Bridging the Gap: From Molecular Residual Disease to Curative Opportunity: Circulating Tumor DNA–Guided Surveillance After Curative Resection for Stage I to III Colorectal Cancer. Journal of Clinical Oncology. 2026;44(32):3083-3087. doi:10.1200/jco-26-01914

BibTeX
@article{Aujla2026,
  author = {Aujla, Amandeep and Ahmed, Jibran},
  title = {Bridging the Gap: From Molecular Residual Disease to Curative Opportunity: Circulating Tumor DNA–Guided Surveillance After Curative Resection for Stage I to III Colorectal Cancer},
  journal = {Journal of Clinical Oncology},
  year = {2026},
  volume = {44},
  number = {32},
  pages = {3083--3087},
  doi = {10.1200/jco-26-01914}
}
Kostenlos starten →